The Cambridge Index declined 1,544.4 points or 7.4% to close at 19,282.3, as six out of the top ten index heavyweights posted ...

PLC (LON:4BB – Get Free Report) insider Heikki Lanckriet purchased 2,400 shares of the business’s stock in a transaction that occurred on Wednesday, April 2nd. The stock was acquired at an average ...

4basebio (AIM: 4BB) is an innovation driven life biotechnology company focused on accelerating the development of advanced therapy medicinal products (ATMPs) through its high-performance synthetic DNA ...

4basebio PLC (AIM: 4BB) (“4basebio”), a company which develops and commercializes the large-scale manufacture of synthetic DNA as well as nanoparticle delivery solutions, today announced that it has ...

4basebio PLC (“4basebio”), a company which develops and commercializes the large-scale manufacture of synthetic DNA as well as nanoparticle delivery solutions, today announced that it has ...

4basebio PLC has been granted Good Manufacturing Practice (GMP) certification by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA). This licence authorises the supply of GMP-grade ...

4basebio announced on Wednesday that it has received Good Manufacturing Practice (GMP) certification from the UK’s Medicines and Healthcare Products Regulatory Agency for its DNA manufacturing ...

PLC ("4basebio" or the "Company") 4basebio Receives GMP Licence for its UK DNA Manufacturing Facility. Cambridge, UK, 2 April 2025 – 4basebio PLC (AIM: 4BB), an innovat ...

Cambridge, UK, 02 April 2025 – 4basebio PLC, a company which develops and commercialises the large-scale manufacture of synthetic DNA as well as nanoparticle delivery solutions, announces that it has ...

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal ...